zinc sulfate supplementation in Glioblastoma multiform
Phase 2
- Conditions
- Glioblastoma multiform.Malignant neoplasm of brain
- Registration Number
- IRCT20190430043432N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 27
Inclusion Criteria
New diagnosed patients with glioblastoma multi form
Normal function of liver, kidneys and hematologic system
Normal zinc and cupper serum levels
Exclusion Criteria
Pregnancy
History of another malignancy
History of allergy to zinc sulfate supplementation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ifetime from diagnosis to death. Timepoint: Every 3 months to at least 12 months. Method of measurement: Visit the patients and find out if they are alive (Survival Calculation by Week).
- Secondary Outcome Measures
Name Time Method